MYLK and breast cancer: Conversely, in the mouse mammary tumour cell line 168FARN, the knockdown of ANXA1 inhibited the invasion and metastasis of breast cancer (Tu et al., 2017), with less expression of epithelial–mesenchymal transition (EMT) markers, wave proteins and myosin light-chain kinase.